Headhunters in the pharmaceutical industry analyze the changing trend of talent demand in China's pharmaceutical industry

According to the analysis of the headhunting consultant of shangxianda headhunting company in the pharmaceutical industry, according to the current regulatory policies and industry development trend, the talent demand structure of the pharmaceutical industry is likely to change greatly 1、 The demand for medical R & D talents will increase significantly In recent years, the policies of the pharmaceutical industry, such as the new regulations of new drug approval and the consistency evaluation of generic drugs in the opinions on the reform of the review and approval system of pharmaceutical and medical devices, the guidance on strengthening and promoting the scientific and technological innovation of food and drugs, and the special plan for scientific and technological innovation of traditional Chinese medicine during the 13th five year plan, all emphasize the innovative research and development It is important to promote the development of new medical technology and realize precision medicine The main direction of the development of pharmaceutical industry is to encourage innovative R & D pharmaceutical enterprises will make strategic plans to increase R & D investment and strength The core is to increase R & D capital investment and R & D talents investment, further recruit talents and cultivate corresponding excellent R & D talents at the R & D end The training cycle of medical R & D talents is very long The stock of medical R & D talents in our country is in short supply, and the increment is insufficient Senior R & D talents and core R & D talents will be hard to find In the future, the competition for R & D talents, especially for core R & D talents, will enter a white hot stage, and the salary of R & D talents will increase The rapid development of China's pharmaceutical R & D Contract outsourcing service cro enterprises and the massive expansion of corresponding talents reflect this trend; the growth rate of the pharmaceutical R & D headhunting positions in shangxianda headhunting company in recent two years has been 18% and 21% respectively, which also reflects this trend from the side In pharmaceutical headhunting projects, R & D positions usually include clinical research and analysis senior talents, pharmaceutical device registration management talents, medical management talents, R & D project management talents, product management talents, process synthesis senior talents, clinical data management and clinical supervision senior talents, etc 2、 Medical quality management talents will be paid more attention In addition to price reduction, the centralized purchase system also needs to guarantee quality Shangxianda pharmaceutical industry headhunting consultant believes that the emphasis on drug safety and quality assurance cannot be overemphasized In particular, after some major drug and vaccine safety accidents in recent years, people's nerves are frequently and strongly stimulated Whether it's chemical drugs, generic drugs, vaccines, or proprietary Chinese medicine, medical equipment, etc., the quality standards in relevant fields need to be improved urgently, the quality supervision will be more strict, and the punishment for quality problems will be increased It is a profound lesson for immortality to be pulled to the bottom because of vaccine quality problems and resolutely delisted Pharmaceutical enterprises must put drug quality in a higher position of development, through the cultivation and introduction of better quality management personnel, optimize the allocation of quality management personnel, improve the voice of quality management personnel, strengthen the level of quality management, and ensure that the quality and safety problems will not bring "extinction" to enterprises For pharmaceutical companies that want to expand their overseas market, it is also necessary to introduce and allocate quality management talents who are familiar with overseas quality standards and have overseas pharmaceutical quality certification background, and such talents will be greatly welcomed by pharmaceutical companies Generally speaking, the overall demand for quality management talents will be improved Such headhunting positions usually include vice president of quality, quality director, manager of quality department, etc 3、 The demand for medical overseas marketing management talents will increase The integration of domestic and foreign markets in the pharmaceutical industry is accelerating, and the import and export volume of drugs in China is growing rapidly year by year According to Shang Xianda's headhunting consultant in the pharmaceutical industry, by 2017, China's pharmaceutical products had achieved a total import and export volume of US $116.68 billion, including US $55.880 billion in imports, US $60.8 billion in drug exports and US $4.92 billion in trade surplus From January to November 2018, the export volume of China's pharmaceutical products was 932000 tons; from January to November, the export volume of China's pharmaceutical products was US $15.9 billion, an increase of nearly 20% year on year In addition to the pharmaceutical companies that set up overseas markets in the early years, with a large number of pharmaceutical products unable to be centrally purchased by the domestic government, the pharmaceutical companies will increase the export of drugs overseas, and the demand and allocation of talents for overseas market expansion of the pharmaceutical industry will increase Those who have rich overseas development management experience and channels and strong overseas business development ability will be more popular and popular with pharmaceutical enterprises Pharmaceutical overseas headhunting positions usually include general manager of overseas business department, deputy general manager or director of overseas marketing, general manager of overseas subsidiaries, director of overseas regions, overseas registration or marketing management talents, etc 4、 Drug e-commerce talents will be more useful Although the development of pharmaceutical e-commerce is not very smooth at present, with the popularization of online purchase of health products, the promotion of pharmaceutical companies, the general trend of prescription outflow and the promotion of electronic prescription, the market prospect of pharmaceutical e-commerce in China is still very broad In the domestic market competition, in addition to entering the drug government procurement catalogue, the huge online drug market is also an important battlefield Some important pharmaceutical circulation enterprises, pharmaceutical enterprises, Internet giants and even giants outside the pharmaceutical circle are covetous for this huge market They have invested heavily in building the corresponding pharmaceutical Internet platform or ecological chain, and more enterprises and capital will enter in the future Corresponding headhunting positions and talent demands of pharmaceutical e-commerce mainly include senior talents of pharmaceutical e-commerce operation management, such as general manager of e-commerce business department, deputy general manager or director of e-commerce operation, senior technical talents of platform development, senior talents of big data mining and analysis, senior talents of data marketing, etc 5、 Overseas excellent biomedical talents returned quickly In order to attract overseas high-level talents to return to China for entrepreneurship and development, China's governments at all levels have promulgated a series of talent attraction and encouragement plans, such as the hundred talents plan, the thousand talents plan, Chunhui plan, the Yangtze River scholars award plan and many talent introduction plans in various cities, of which nearly one third are excellent scientists and senior technicians in the field of biomedicine Shangxianda pharmaceutical industry headhunting consultant noted that in recent years, the number and proportion of returned biomedical talents studying abroad are increasing year by year; some excellent pharmaceutical enterprises are also increasing the attraction of foreign talents in biomedical industry, especially senior R & D talents and overseas market expansion talents; The number of Chinese working in overseas pharmaceutical companies and "returnees" returning to China is also increasing year by year; in addition, due to various reasons, the number of outflow of middle and senior managers from famous domestic biomedical foreign companies has increased in recent years All these have created better conditions for domestic pharmaceutical enterprises to seize outstanding talents Six, the demand for senior talents of investment and merger will increase In recent years, M & A among pharmaceutical enterprises is very hot In addition, the merger and reorganization of listed companies has cancelled the administrative review, and the pharmaceutical industry reform policies have different significant and far-reaching impact on pharmaceutical enterprises In the future, the merger and acquisition activities of pharmaceutical enterprises will be more active, the pace of merger and reorganization will be faster, and the whole industry will accelerate into the stage of survival of the fittest Industry + capital will become an important model for the development of many large and medium-sized pharmaceutical enterprises According to Shang Xianda's headhunting consultant in the pharmaceutical industry, 140 m & A events took place in the pharmaceutical and health listed companies from January to June 2018, with a total amount of nearly 66 billion yuan, involving bio pharmaceutical enterprises, medical service institutions, retail pharmacies and other fields In order to optimize the allocation of resources, improve the competitive situation, and obtain more development opportunities, the demand for investment and M & A talents of large and medium-sized pharmaceutical enterprises will be growing The headhunting positions involved mainly include vice president of investment, chief investment officer, senior investment analysis and risk control talents, etc 7、 The demand for compound high-end management talents will increase With the decline of macro-economic growth, frequent medical policies, intensified industry competition, accelerated market changes, higher costs, blurred industry boundaries, the sustained and healthy development of pharmaceutical enterprises is facing more uncertain external environment and more severe internal and external challenges This puts forward higher requirements for management talents of pharmaceutical enterprises, especially for compound management talents Not only to be proficient in this professional ability, but also to master other related professional ability; not only to be proficient in the pharmaceutical industry, but also to be familiar with other related industries For example, the medical e-commerce senior talents not only need to be proficient in e-commerce and information technology, but also be familiar with the pharmaceutical industry and drugs, not only need to be proficient in fine technology, but also understand the market; the R & D management talents, not only need to be proficient in drug research and development, but also need to be proficient in pharmaceutical matters and regulations, understand the market and registered composite talents Senior R & D personnel may be involved in genetic engineering, artificial intelligence, data science and computer technology, etc 8、 Environmental health and safety talents will be paid more attention With the increasingly strict requirements of national standards for environmental protection and occupational health and safety, the attention and investment of pharmaceutical enterprises on environment and occupational health and safety have been significantly improved, and the professional requirements and the number of talents required by medical enterprises have also been improved The positions related to headhunting are mainly director, Department Manager and director of environmental protection and safety 9、 The demand for medical domestic sales talents will be significantly reduced With the implementation of the medical representative filing system, three decisions and one ownership, face recognition, innocence certificate, and whole process monitoring policies in major hospitals in Shanghai, Tianjin, Zhengzhou and other places, the pharmaceutical enterprises are forced to develop in the direction of academic promotion and compliance The "4 + 7" urban volume procurement led by the state health insurance bureau will be implemented in Shanghai, and the centralized procurement negotiation mode will probably be popularized from the pilot to the whole country, which will have a profound impact on the sales system of pharmaceutical manufacturing enterprises Pharmaceutical enterprises have to reconstruct the sales operation system, significantly reduce the demand for pharmaceutical sales personnel, reduce the salary of pharmaceutical sales personnel, and maintain the demand for some sales personnel from the previous relationship Transfer personnel to marketing or academic promotion personnel The positions involved are mainly domestic sales representatives, middle and basic level sales management personnel, channel personnel, investment promotion personnel, business personnel, public relations personnel, etc 10、 The demand for pharmaceutical production personnel will decrease day by day The decrease trend of medical production talents is mainly reflected in the demand for production personnel at the grass-roots level There are two main reasons: first, in order to improve production efficiency, control product quality and reduce labor costs, more and more pharmaceutical enterprises generally promote the application of automatic production, intelligent production and unmanned workshop, which will greatly reduce the demand for production personnel, and as a whole, this is an irreversible trend Second, since 2018, under the influence of factors such as the overall promotion of consistency evaluation, the preliminary implementation of the new classification reform scheme for chemical registration, and the flow of drug clinical trial data verification, most enterprises have been impacted and their production momentum has declined; Looking forward to 2019 and beyond, under the influence of factors such as the drug listing permit holder system, strengthening quality supervision, centralized purchase and promotion, the pharmaceutical industry will control the number of existing drug varieties and even existing drug manufacturers, from optimizing stock varieties and stock manufacturers, reducing the low-end supply and ineffective supply in the field of medicine, and realizing capacity reduction, which will also affect the production of the pharmaceutical industry Class Author: headhunting consultant of pharmaceutical industry of shangxianda headhunting company